NO20020622L - Polymorfer av torsemid - Google Patents

Polymorfer av torsemid

Info

Publication number
NO20020622L
NO20020622L NO20020622A NO20020622A NO20020622L NO 20020622 L NO20020622 L NO 20020622L NO 20020622 A NO20020622 A NO 20020622A NO 20020622 A NO20020622 A NO 20020622A NO 20020622 L NO20020622 L NO 20020622L
Authority
NO
Norway
Prior art keywords
torsemide
polymorphs
Prior art date
Application number
NO20020622A
Other languages
English (en)
Norwegian (no)
Other versions
NO20020622D0 (no
Inventor
Judith Aronhime
David Leonov
Marko Kordova
Anchel Schwartz
Ben-Zion Dolitzky
Original Assignee
Teva Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharma filed Critical Teva Pharma
Publication of NO20020622D0 publication Critical patent/NO20020622D0/no
Publication of NO20020622L publication Critical patent/NO20020622L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Details Of Garments (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Pressure Welding/Diffusion-Bonding (AREA)
NO20020622A 1999-08-11 2002-02-08 Polymorfer av torsemid NO20020622L (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US14830599P 1999-08-11 1999-08-11
US18312700P 2000-02-17 2000-02-17
US21527300P 2000-06-30 2000-06-30
PCT/US2000/022081 WO2001010441A1 (en) 1999-08-11 2000-08-11 Torsemide polymorphs

Publications (2)

Publication Number Publication Date
NO20020622D0 NO20020622D0 (no) 2002-02-08
NO20020622L true NO20020622L (no) 2002-03-14

Family

ID=27386674

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20020622A NO20020622L (no) 1999-08-11 2002-02-08 Polymorfer av torsemid

Country Status (24)

Country Link
US (1) US6465496B1 (zh)
EP (1) EP1207880A4 (zh)
JP (1) JP2003527319A (zh)
KR (1) KR20020025217A (zh)
CN (1) CN1378448A (zh)
AU (1) AU781461C (zh)
BG (1) BG106400A (zh)
CA (1) CA2379322A1 (zh)
CZ (1) CZ2002404A3 (zh)
DE (1) DE00957398T1 (zh)
ES (1) ES2204354T1 (zh)
HK (1) HK1046636A1 (zh)
HR (1) HRP20020120A2 (zh)
HU (1) HUP0204318A3 (zh)
IL (1) IL148031A0 (zh)
LT (1) LT5004B (zh)
MX (1) MXPA02001369A (zh)
NO (1) NO20020622L (zh)
PL (1) PL354262A1 (zh)
SI (1) SI20816A (zh)
SK (1) SK1912002A3 (zh)
TR (1) TR200200353T2 (zh)
WO (1) WO2001010441A1 (zh)
YU (1) YU9502A (zh)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2410802A1 (en) * 2000-02-17 2002-09-06 Minutza Leibovici A stable pharmaceutical formulation comprising torsemide modification ii
DE10013289A1 (de) * 2000-03-17 2001-09-20 Knoll Ag Torasemid enthaltende pharmazeutische Zubereitungen
HRP20000162B1 (en) 2000-03-20 2004-06-30 Pliva D D Amorphous torasemide modification
US20030022921A1 (en) * 2001-02-21 2003-01-30 Minutza Leibovici Stable pharmaceutical formulation comprising torsemide modification II
EP1397343A1 (en) 2001-05-31 2004-03-17 Orion Corporation Fermion Process for preparing sertraline hydrochloride polymorphic form ii
IN192178B (zh) 2001-08-03 2004-03-06 Ranbaxy Lab
US20030119882A1 (en) * 2001-10-22 2003-06-26 Markus Maegerlein Solid pharmaceutical composition containing torasemide
ITMI20020639A1 (it) * 2002-03-27 2003-09-29 Cosma S P A Composizioni farmaceutiche comprendenti come principio attivo 1-isopropil-3°(4-m-toluidino-3-pridil)sulfonil!-urea
HRP20020603B1 (en) * 2002-07-19 2008-11-30 Pliva D.D. New process for the preparation of modification i n-(1-methylethylaminocarbonyl)-4-(3-methylphenylamino)-3-pyridinesulfonamide
CA2424644A1 (en) * 2003-04-07 2004-10-07 David John Mckenzie Preparation of torasemide
ES2244324B1 (es) * 2004-03-25 2006-11-16 Ferrer Internacional, S.A. Composiciones diureticas de liberacion prolongada.
AT500576B1 (de) * 2004-07-28 2006-11-15 Sanochemia Pharmazeutika Ag Verfahren zur reindarstellung von kristallformen von torsemid
KR100845383B1 (ko) * 2004-12-24 2008-07-09 일동제약주식회사 토르세미드 변형체(ⅰ)의 제조방법
US20070122483A1 (en) * 2005-11-29 2007-05-31 Sharon Myers Fluocinolone acetonide drug substance polymorphic interconversion
TWI665190B (zh) 2013-11-15 2019-07-11 阿克比治療有限公司 ｛［５－（３－氯苯基）－３－羥基吡啶－２－羰基］胺基｝乙酸之固體型式，其組合物及用途
CN105949115A (zh) * 2016-05-26 2016-09-21 南京正科医药股份有限公司 一种新晶型托拉塞米
CN115417810B (zh) * 2022-09-22 2023-10-10 南京正科医药股份有限公司 一种托拉塞米晶型ⅰ的精制方法
CN117486789A (zh) * 2023-12-29 2024-02-02 江西中医药大学 一种托拉塞米共晶盐及其制备方法和应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US34672A (en) 1862-03-18 Improved convertible boat, bridge, and tent
US30633A (en) 1860-11-13 Improvement in fire-escapes
US4055650A (en) 1974-04-17 1977-10-25 A. Christiaens Societe Anonyme Certain 4-phenoxy(or phenylthio)-3-n-acylated-sulfonamido-pyridines
GB1477664A (en) 1974-04-17 1977-06-22 Christiaens Sa A Pyridine derivatives
DE3529529A1 (de) 1985-08-17 1987-02-19 Boehringer Mannheim Gmbh Verfahren zur herstellung einer stabilen modifikation von torasemid
DE3623620A1 (de) 1986-07-12 1988-01-21 Boehringer Mannheim Gmbh Spritzfertige, waessrige, alkalische injektionsloesungen von torasemid und verfahren zu ihrer herstellung
HRP980532B1 (en) * 1998-10-02 2005-06-30 Pliva Novel crystalline torasemide modification
US6166045A (en) * 1998-06-02 2000-12-26 Roche Diagnostics Gmbh Torasemide of modification III
US5914336A (en) * 1998-06-02 1999-06-22 Boehringer Mannheim Gmbh Method of controlling the serum solubility of orally administered torasemide and composition relating thereto
HRP20000162B1 (en) * 2000-03-20 2004-06-30 Pliva D D Amorphous torasemide modification
WO2001070226A1 (en) * 2000-03-20 2001-09-27 Teva Pharmaceutical Industries Ltd. Novel processes for preparing torsemide intermediate
HRP20000328A2 (en) * 2000-05-19 2002-02-28 Pliva Farmaceutska Ind Dionik Novel polymorph v of torasemide

Also Published As

Publication number Publication date
LT2002017A (en) 2002-11-25
YU9502A (sh) 2005-06-10
HK1046636A1 (zh) 2003-01-24
AU6902600A (en) 2001-03-05
BG106400A (en) 2002-08-30
IL148031A0 (en) 2002-09-12
CZ2002404A3 (cs) 2002-06-12
NO20020622D0 (no) 2002-02-08
HUP0204318A3 (en) 2005-03-29
KR20020025217A (ko) 2002-04-03
CN1378448A (zh) 2002-11-06
LT5004B (lt) 2003-03-25
EP1207880A1 (en) 2002-05-29
HUP0204318A2 (en) 2003-05-28
WO2001010441A1 (en) 2001-02-15
AU781461B2 (en) 2005-05-26
MXPA02001369A (es) 2005-08-26
TR200200353T2 (tr) 2002-06-21
SK1912002A3 (en) 2002-07-02
PL354262A1 (en) 2003-12-29
ES2204354T1 (es) 2004-05-01
SI20816A (sl) 2002-08-31
DE00957398T1 (de) 2004-04-15
JP2003527319A (ja) 2003-09-16
HRP20020120A2 (en) 2003-10-31
EP1207880A4 (en) 2004-09-01
CA2379322A1 (en) 2001-02-15
AU781461C (en) 2006-02-23
US6465496B1 (en) 2002-10-15

Similar Documents

Publication Publication Date Title
NO20054715L (no) Fremgangsmater og mellomprodukter for fremstilling av anti-cancer forbindelser
NO20020622L (no) Polymorfer av torsemid
NO20031626D0 (no) Pyridonderivater for behandling av atherosklerose
DK1218382T3 (da) Bicykliske imidazo-3-ylaminderivater
NO20013965D0 (no) Aktivering av nedihullsanordninger
DE50015443D1 (de) Bicyclische imidazo-5-yl-aminderivate
ATE270270T1 (de) Neuartige phenylalkyloxy-phenyl-derivate
PT1246817E (pt) Derivados de 4-fenil-1-piperazinilo, -piperidinilo e -tetra-hidropiridilo
NO20021124L (no) Fremgangsmåte for fremstilling av benzoksazinderivater og mellomprodukter derfor
NO20016151D0 (no) Fremstilling av substituerte piperidin-4-oner
PT1178984E (pt) Derivados de 1-trifluorometil-4-hidroxi-7-piperidinilamimometilcromano
NO20006279D0 (no) Generator for produksjon av fotonantalltilstand
ID24327A (id) Produksi senyawa-senyawa avermektin
NO20013407D0 (no) Fremgangsmåte for fremstilling av kinolinkarbaldehyd
FI19991831A (fi) Eristysmateriaalien pinnoite
PT1175417E (pt) Compostos substituidos de benzolactamas
NO20013995L (no) Fremgangsmåte for fremstilling av L-sorbose
NO20014845D0 (no) Anvendelse av arylalkanoylpyridaziner
PT1232141E (pt) Eteres de o-desmetil-venlafaxina
NO20020328D0 (no) Fremgangsmåte for fremstilling av 4-cyano-2-aminometyltiazol
PT1020132E (pt) Aba de puxar destacavel
NO993313L (no) Derivater av 5-nitrofurfural
NO20020327D0 (no) Fremgangsmåte for fremstilling av 2-aminometyl-4-cyano-tiazol
EE200200053A (et) Isoretinoiini valmistamise protsess
SE9902239D0 (sv) Kornisch bestående av flera delar

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application